FDA Adverse Event Death Summary report: N

FARAWAVE NAV

MDR report key: 23238796 · Received October 7, 2025

Report

Report Number
2124215-2025-71072
Event Type
Death
Date Received
October 7, 2025
Date of Event
September 25, 2025
Report Date
October 7, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
QZI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC DUE TO THE TIMING OF THE ADVERSE EVENT POST PROCEDURE. BECAUSE THE PRODUCT IS UNKNOWN, WE ARE UNABLE TO PROVIDE THE UNIQUE IDENTIFIER (UDI) AND OTHER SPECIFIC PRODUCT INFORMATION. IT WAS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 0

THE PATIENT PRESENTED WITH PERSISTENT ATRIAL FIBRILLATION AND THE PHYSICIAN DECIDED TO TREAT THE PATIENTS' PULMONARY VEINS AND POSTERIOR WALL WITH PULSED FIELD ABLATION WITH A FARAWAVE NAV CATHETER. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH NO COMPLICATIONS AND TO OUR KNOWLEDGE LEFT THE LAB IN SINUS RHYTHM. IT WAS REPORTED THAT THE PATIENT HAD DIED A DAY AFTER THE PROCEDURE. NO FURTHER INFORMATION WAS PROVIDED. THE DEVICE IS NOT EXPECTED TO RETURN FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1440632 FARAWAVE NAV CARDIAC IRREVERSIBLE ELECTROPORATION SYSTEM CATHETER QZI BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 80 YR Unknown Death